IGF2BP1 and cancer: In addition, the findings presented here strongly suggest that the de novo synthesis of IGF2BP1 is further promoted by the downregulation of the let-7 family, supporting a pro-oncogenic, let-7 antagonizing role previously demonstrated for IGF2BP1 in other cancer models [11,39].